NEW YORK (GenomeWeb News) — Interleukin Genetics will collaborate with Pennsylvania-based Geisinger Health System to study the role of certain genes in obesity, the company said today.
The aim of the project is to develop genetic tests that will indicate a patient's inherited
resistance to weight loss "and, more specifically, gauge a patient's likelihood of success with diet and other weight loss techniques," the company said. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.